Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KATHERINE Z HOLCOMB

Allopathic & Osteopathic Physicians Dermatology

NPI
1861668808
CMS profile
672937
Location
METAIRIE, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$61,367.70

211 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 5; records 51–100 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KATHERINE Z HOLCOMB

NPI 1861668808 · CMS profile ID 672937

Allopathic & Osteopathic Physicians / Dermatology

METAIRIE, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1861668808?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KATHERINE Z HOLCOMB, NPI 1861668808, CMS profile ID 672937. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1861668808?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). KATHERINE Z HOLCOMB, NPI 1861668808, CMS profile ID 672937. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1861668808?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
KATHERINE Z HOLCOMB, NPI 1861668808, CMS profile ID 672937, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 211 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1861668808?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

211 matching records · $61,367.70 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 211 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 211.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Allergan, Inc. $414.1810/30/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805727 CMS
Allergan, Inc. $92.7910/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805699 CMS
LEO Pharma Inc. $25.0110/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842204139 CMS
Galderma Laboratories, L.P. $5.8110/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855280143 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $7.7010/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849557367 CMS
Regeneron Healthcare Solutions, Inc. $90.1910/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 809587243 CMS
GENZYME CORPORATION $23.8610/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843591643 CMS
Novartis Pharmaceuticals Corporation $9.7910/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812720503 CMS
AbbVie Inc. $17.4910/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794845789 CMS
Galderma Laboratories, L.P. $34.4910/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855280139 CMS
Galderma Laboratories, L.P. $7.8410/12/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855280141 CMS
Novartis Pharmaceuticals Corporation $16.6710/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812720501 CMS
Galderma Laboratories, L.P. $1.9210/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855280137 CMS
PFIZER INC. $17.7110/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832893731 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $14.3610/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851898387 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $8.8310/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849557365 CMS
AbbVie Inc. $13.7110/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794845785 CMS
Allergan, Inc. $500.0010/05/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805697 CMS
Galderma Laboratories, L.P. $10.0010/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855280135 CMS
AbbVie Inc. $17.6710/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794845781 CMS
Allergan, Inc. $118.9010/04/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805695 CMS
Allergan, Inc. $17.0409/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805693 CMS
Novartis Pharmaceuticals Corporation $6.3609/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812720499 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $14.4109/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 851898389 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $8.3209/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849557363 CMS
Biofrontera Inc. $9.2109/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815383831 CMS
Galderma Laboratories, L.P. $16.7209/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855280133 CMS
GENZYME CORPORATION $24.1309/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843591635 CMS
Allergan, Inc. $297.4009/08/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805691 CMS
Allergan, Inc. $127.6508/27/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805685 CMS
Allergan, Inc. $1,380.0008/27/2021 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805687 CMS
Allergan, Inc. $57.6708/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805689 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $7.5408/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849557361 CMS
PFIZER INC. $15.0408/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832808669 CMS
MAYNE PHARMA INC. $24.3008/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849501119 CMS
UCB, Inc. $20.4408/19/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807392129 CMS
AbbVie Inc. $23.7208/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794845777 CMS
Galderma Laboratories, L.P. $6,000.0008/16/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855280131 CMS
AbbVie Inc. $26.9508/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 794845773 CMS
GENZYME CORPORATION $6.1408/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843591617 CMS
UCB, Inc. $26.0408/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 807379227 CMS
Galderma Laboratories, L.P. $3.6308/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855280129 CMS
VYNE Pharmaceuticals Inc. $13.9408/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 830830753 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $7.7008/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849557359 CMS
Allergan, Inc. $97.4008/03/2021 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792805683 CMS
LEO Pharma Inc. $23.5007/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 842204131 CMS
Almirall LLC $19.2707/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819695837 CMS
GENZYME CORPORATION $20.7907/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843591611 CMS
Novartis Pharmaceuticals Corporation $16.7507/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812720497 CMS
Novartis Pharmaceuticals Corporation $18.3807/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 812720495 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $49,535.24 175
PY2020 $24,810.40 90
PY2021 $61,367.70 211
PY2022 $49,553.70 240
PY2023 $115,659.45 269
PY2024 $56,873.94 206
PY2025 $53,600.68 212

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $253,655.51 28
PY2024 Principal investigator $18,492.00 3
PY2022 Principal investigator $8,000.00 1
PY2021 Principal investigator $4,203.70 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

28 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $31,356.26 12/31/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A Multicenter, Blinded, Randomized, Parallel-Group, Comparator-Controlled Study of the Safety and Effectiveness of HArmonyCa Lidocaine Injectable Gel for Mid-Face Soft Tissue Augmentation No dispute reported 06/30/2026 1202532941
Principal investigator 1 ABBVIE INC. $9,166.68 12/31/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A multicenter, evaluator and subject-blinded, randomized, comparator-controlled, parallel-design study to evaluate the safety and effectiveness of NOA VOLUME compared to JUVEDERM VOLUMA XC for improvement of mid-face volume No dispute reported 06/30/2026 1202532943
Principal investigator 1 ABBVIE INC. $8,420.82 12/31/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A Prospective, Open-Label Study to Evaluate Subject Satisfaction with Overall Facial Appearance After Treatment with JUVeDERM Products in Medical Weight Loss (MWL) Subjects No dispute reported 06/30/2026 1202532945
Principal investigator 1 ABBVIE INC. $18,620.00 12/18/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A Study to Evaluate the Safety and Effectiveness of JUVEDERM Products in Adult Participants for the Change of Their Overall Facial Appearance No dispute reported 06/30/2026 1202531306
Principal investigator 1 ABBVIE INC. $148.56 12/11/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A Study to Evaluate the Safety and Effectiveness of JUVEDERM Products in Adult Participants for the Change of Their Overall Facial Appearance No dispute reported 06/30/2026 1202530226
Principal investigator 1 ABBVIE INC. $3,274.76 12/04/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202528512
Principal investigator 1 ABBVIE INC. $5,000.00 11/04/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants with Schizophrenia Bipolar I Disorder or Autism Spectrum Disorder No dispute reported 06/30/2026 1202521193
Principal investigator 1 ABBVIE INC. $5,619.60 11/04/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202521233
Principal investigator 1 ABBVIE INC. $288.60 10/15/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202517013
Principal investigator 1 ABBVIE INC. $337.39 10/15/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202517015
Principal investigator 1 ABBVIE INC. $283.06 10/14/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202516719
Principal investigator 1 ABBVIE INC. $7,492.80 10/09/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202516051
Principal investigator 1 ABBVIE INC. $12,000.00 09/19/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A multicenter, double-blind, randomized, parallel-group, controlled study to evaluate the safety and effectiveness of ELAPR002f injectable gel in adult participants with atrophic acne scars No dispute reported 06/30/2026 1202511680
Principal investigator 1 ABBVIE INC. $1,350.00 09/18/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202511568
Principal investigator 1 ABBVIE INC. $3,746.40 09/03/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202508208
Principal investigator 1 ABBVIE INC. $1,000.00 08/14/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202504945
Principal investigator 1 ABBVIE INC. $9,824.28 08/05/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202502232
Principal investigator 1 ABBVIE INC. $451.73 08/01/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202500852
Principal investigator 1 ABBVIE INC. $1,500.00 07/24/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants with Schizophrenia Bipolar I Disorder or Autism Spectrum Disorder No dispute reported 06/30/2026 1202499606
Principal investigator 1 ABBVIE INC. $4,500.00 07/21/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202499062
Principal investigator 1 ABBVIE INC. $2,500.00 07/16/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants with Schizophrenia Bipolar I Disorder or Autism Spectrum Disorder No dispute reported 06/30/2026 1202498414
Principal investigator 1 ABBVIE INC. $3,274.76 07/02/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202496693
Principal investigator 1 ABBVIE INC. $2,755.20 06/25/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
A 26-Week Multicenter Open-Label Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Participants with Schizophrenia Bipolar I Disorder or Autism Spectrum Disorder No dispute reported 06/30/2026 1202492893
Principal investigator 1 ABBVIE INC. $13,570.76 06/03/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202489891
Principal investigator 1 ABBVIE INC. $26,330.51 05/07/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202484147
Principal investigator 1 ABBVIE INC. $33,891.02 04/03/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202474318
Principal investigator 1 ABBVIE INC. $40,619.27 03/07/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 - M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202462069
Principal investigator 1 ABBVIE INC. $6,333.05 02/06/2025 Non-covered Recipient Entity
H&H RESEARCH LLC
M21-841 - M21-841 NOA Volume - Mid Face US Pivotal Study No dispute reported 06/30/2026 1202449082